)
AstraZeneca Pharma India today reported a standalone net loss of Rs 13.40 crore for the third quarter ended December 2014.
The company had reported a net profit of Rs 1.51 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma said in a filing to BSE.
The company's standalone total income from operations stood at Rs 108.20 crore for the quarter under consideration.
It was Rs 118.95 crore for the same period a year ago.
Shares of AstraZeneca Pharma India were trading 0.18% down at Rs 867 per scrip during afternoon session on the BSE.
